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Interleukin 2 inhibits follicular T helper cells and promotes Foxp3-expressing 
regulatory T cell generation. Ballesteros-Tato and colleagues shows that things 
are more complex for Tfr cell generation. 
 
 
Germinal centers (GCs) form in secondary lymphoid tissues after infection or 
immunization, producing both memory B cells and antibody-secreting plasma cells 
that provide protection against subsequent infection1. GCs are absolutely dependent 
on T follicular helper (TFH) cells for their formation and maintenance, and contain a 
population of Foxp3+ follicular regulatory T (TFR) cells whose biology has remained 
enigmatic since their discovery in 2011 (ref. 2). In this issue of Nature Immunology, 
Ballesteros-Tato and colleagues demonstrate an inhibitory role of interleukin 2 (IL-2) 
in TFR cell differentiation, and show that preventing TFR cell differentiation results in 
increased production of antibody-secreting plasma cells, including those with self-
reactive specificity3. 
 
In contrast to TFH cells, which provide help to GC B cells, TFR cells have a 
suppressive function and are thought to limit the GC response. Despite their 
regulatory capacity, TFR cells phenotypically resemble TFH cells, expressing CXCR5, 
PD-1, and Bcl-6, the transcription factor that is essential for both TFH and TFR cell 
differentiation4–6. One common feature of both TFH and TFR cells that they do not 
express CD25, the α chain of the high-affinity interleukin 2 (IL-2) receptor4,7,8. In 
primed CD4+ T cells signaling via CD25 inhibits Bcl6 expression, thereby preventing 
TFH cell differentiation2. However, it is not clear why TFR cells do not express CD25; 
this is especially paradoxical as Foxp3+ regulatory T (Treg) cells require IL-2 signaling 
for their maintenance. Ballesteros-Tato and colleagues now show that abundance of 
IL-2 also suppresses TFR cell differentiation (Fig. 1)3. In the context of influenza 
1  
infection this mechanism delays the differentiation of TFR cells from Foxp3+ 
precursors until IL-2 concentrations have declined. An inhibitory role of IL-2 on TFR 
cell formation was recently also reported by another group8. IL-2 suppresses TFH cell 
development by inducing STAT5 phosphorylation, a mechanism that is dependent on 
Blimp-1 expression2. Blimp-1 limits the size of the TFR cell population in a cell-
intrinsic way4, and, interestingly, enhancing IL-2 availability in Blimp-1-deficient 
cells does not inhibit TFR cell accumulation, suggesting that an IL-2–STAT5–Blimp-1 
axis represses TFR cell differentiation. However, not all Blimp-1-negative Treg cells 
are TFR cells, indicating that other signals events need to be delivered in parallel with 
IL-2 withdrawal before a Treg cell is able to become a TFR cell3.      
 
Intriguingly, influenza infection yields IL-2 concentrations sufficient to inhibit TFR, 
but not TFH, cell differentiation3. This difference in responses to IL-2 may be because 
TFR cell precursors are more sensitive to IL-2 than TFH precursors, due to higher 
CD25 expression. CD25 is expressed by the majority of Treg cells and signaling via 
this receptor is essential for their survival and expansion under homeostatic 
conditions9. However, like TFR cells, some Treg cells do not express CD25; Treg cells 
expressing T-bet, the transcriptional regulator of TH1 cells, and Treg cells with an 
effector/memory phenotype have also down-regulated CD25 expression10,11. Taken 
together, these studies may intimate a model in which “naïve” Treg cells require IL-2 
signaling for their maintenance, but that limiting IL-2 signaling is essential for Treg 
cells to differentiate into effector subsets or memory Treg cells.  
 
The role that TFR cells play in GC biology has been difficult to decipher, with 
multiple studies yielding conflicting results. Initially this was because there was no 
mouse model that specifically lacked TFR cells. Because of this, all in vivo 
experiments were performed using mixed bone marrow chimeras or adoptive cell 
transfers, systems which have limitations. The generation of Bcl6flox/floxFoxp3cre 
animals provides a mouse that specifically lacks TFR cells12. Ballesteros-Tato and 
colleagues3 use this model to demonstrate TFR cells control the formation of antibody-
secreting cells. This dysregulation in the absence of TFR cells is not simply due to a 
change in magnitude of the response, as the antibody specificity is also altered: lack 
of TFR cells does not alter anti-influenza antibody titer, but increases production of 
anti-nuclear autoimmune antibodies after influenza infection. Consistent with the role 2  
of IL-2 in limiting TFR cell formation, treating mice with recombinant IL-2 also 
results in autoantibody production3.  
 
The finding that TFR cells limit the production of self-reactive antibody-secreting 
plasma cells is a key discovery in understanding the biology of these cells. Within the 
GC, B cells undergo somatic hypermutation of the genes encoding their B cell 
receptors. This mutation process is random and can result in the emergence of self-
reactive clones. It is, therefore, essential that the selection of mutated GC B cells is 
stringent, in order to ensure these cells do not exit the GC as long-lived plasma cells 
or memory B cells. Selection within the GC is a process thought to be driven through 
positive feedback to B cells from follicular dendritic cells and TFH cells, while self-
reactive B cells perish through neglect1. The discovery that, in the absence of TFR 
cells, B cells with a self-reactive B cell receptor can emerge from the GC suggests 
that these cells may have an active role in negative B cell selection. Alternatively, TFR 
cells may act to limit the provision of positive signals from either TFH cells or 
follicular dendritic cells. The mechanism by which TFR cells control autoreactivity 
from the GC, and the main cell types on whom they act are pertinent questions in 
understanding not just the role for TFR cells, but the biology of the GC. 
 
 
Legend to Figure 1 
When IL-2 binds the high affinity IL-2 receptor, composed of CD122, the common γ 
chain (γc) and CD25, STAT5 is phosphorylated leading to repression of Bcl6, and 
increase in Blimp1 expression. The lack of Bcl6 and increase in Blimp1 inhibits Tfr 
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